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Detailed final report 
 
In pharmaceutical, toxicological and basic research, there is ever increasing 
demand for replacing mammalian models with new test systems that enable the detection 
of harmful effects. Therefore in silico and in vitro (cell and tissue cultures) approaches 
are more and more frequently used. However, these have limited value and are only 
useful in the early phases of drug discovery and toxicity evaluation, as they cannot 
replicate the complex dynamic, multi-organ events that occur in vivo. Even new 
technologies, like IdMOC (Integrated Discrete Multiple Organ Culture plate), based on 
the co-culture of cell lines from different organs are unable to model the continuous, 
interactive communication of cells and organs perfectly. According to the above and in 
order to reduce cost and comply with animal experimentation directives, researchers have 
been looking for new animal models such as the zebrafish (Danio rerio) or roundworm 
(Caenorrhabditis elegans) because they offer the biological complexity at the level of 
organ and entire organism. Although the new models are lower organisms, their genes, 
receptors, molecular and physiological processes are analogous to those in mammals so 
to humans as well. 
Zebrafish is a popular, well-studied model organism, previously considered as 
an excellent genetic model for developmental biology. The focus of research now shows 
a noticeable shift towards the application of zebrafish as disease model, and test tool in 
pharmacology and toxicology. 
The popularity of zebrafish in toxicological research is mainly due to its small 
size, high tolerance, short generation interval and cheap and easy husbandry. It produces 
a large number of eggs in a single spawning so many embryos/larvae can be obtained in a 
short period of time. Additionally whole genome information and many simple and cheap 
experimental techniques such as gene expression analysis, transgenesis, gene function 
manipulation tools are also available for the species. Organ/tissue and cellular phenotypes 
can easily be observed in the transparent ex utero developing embryos and larvae. 
Manipulation techniques developed for mammals can be used in zebrafish too, but there 
are fish specific methods as well. Zebrafish are able to detect low toxic agent levels. 
Importantly, their embryos and larvae up to the free feeding age are not considered as 
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animals by the Animals (Scientific Procedures) Act 1986 of the UK and the relevant 
Directive 86/609/EEC Art. 2b of the European Union. Thus, promoting the use of 
zebrafish embryos/ larvae instead of rodents, and other laboratory animals including adult 
fish remains a high priority. Somewhat paradoxically, the increasing popularity of 
zebrafish in medical research also led to the increasing number of laboratories in which 
zebrafish is used also after the start of the free feeding stage (such as regeneration, liver 
and cardio toxicity and neurotoxicity, behaviour and cancer). 
Using transgenic zebrafish in medical research is not a novel concept, so 
hundreds or even thousands of transgenic zebrafish lines have been generated in the last 
decade. However the majority of these are single colour lines and the application of 
double transgenics has been sporadic while multiple transgenic lines have not yet been 
reported. 
In the framework of the NNF 78834 project our aim was to develop multiple 
transgenic zebrafish lines based on which new, rapid in vivo embryonal test systems 
could be established. As in case of zebrafish, the chorion and the developing larvae are 
transparent, transgenic lines expressing fluorescent proteins enable the rapid and easy in 
vivo detection of toxic effects. 
If the toxicologically important target organs (liver, blood vessels, blood cells, 
nervous system) are labelled with different fluorescent proteins, toxic effects on these 
organs can be detected simultaneously in a single zebrafish line. 
For the development of the multiple transgenic lines, first we crossed already 
available transgenic lines: two lines that produce fluorescent proteins in the neurotic 
tissues (Neurogenin and Nestin), a line in which the blood cells (GATA-1) and another in 
which the blood vessels (Fli) are labelled with fluorescent proteins. 
Nestin is an intermediate filament protein expressed mostly in dividing nerve 
cells eg. during the radial growth of the axon. Nestin is only expressed during the early 
stages of development in the central nervous system, later on it becomes downregulated 
and replaced by tissue specific intermediate filaments. In adults, nestin expression is 
reinduced in the ijury of the central nervous system as a sign of regeneration. The 
transgenic line was developed by a construct in which the expression of the green 
flurescent protein (GFP) is driven by the nestin promoter. Since in this line, the presence 
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of GFP can only be detected in developing nervous tissues, it is suitable for analysing the 
effects of toxic agents on nervous system development. 
Neurogenin-1 is a tissue specific key protein in the development of the nervous 
system. Neurogenin-1 is expressed only in embryonic neural tissues during the 
development of the neural plate and supports the differentiation of primary neurons. The 
neurogenin transgenic line expresses red fluorescent protein (RFP) under the control of 
the neurogenin promoter, enabling the in vivo detection of toxic effects on neural plate 
development. 
GATA-1 (globin transcription factor-1) is a transcription factor essential for the 
differentiaition of erythroid cells, eosinophyl granulocytes and mastocytes. Playing a key 
role, this protein is one of the best tools to identify haematopoietic tissues. In the 
transgenic line blood cells are labelled with a red fluorescent protein (DsRed) making the 
monitoring of toxic effects possible on these cells and tissues. 
Fli-1 (Friend leukemia integration site-1) is a transcription factor present in the 
blood-forming (haematopoietic) tissues and organs (embryonal ICM, kidney, thymus, 
heart) and also in endothelial cells (interior surface of blood vessels). The transgenic line 
produces green fluorescent protein (GFP) in these cells and organs, making the line 
suitable to monitor toxic effects exerted on the labelled tissues. 
In order to develop multiple transgenic lines, first single transgenic, homozygous 
individuals were crossed. In order to find out the genotype of transgenic individuals, fish 
were crossed to wild type individuals and developing embryos were examined under a 
fluorescent microscope, using the appropriate filter. If all larvae are hemizygous and 
express the fluorescent protein, the transgenic parent was homozygous. But if non-
expressing, wild-type larvae can also be seen amongst, the parent was hemizygous. 
Identified homozygous parents were then crossed to each other and double transgenic 
individuals, hemizygous for the transgenes were derived. In hemizygous fish, the 
transgene is only present in one of the chromosome pairs (Figure 1.). 
 
 
 
 
NNF 77834 Final report 
 
6 
 
 
Figure 1. Crossing scheme of single transgenic lines. One of the parents is homozygous for the „A” and the other for 
the „B” construct. Offspring will get only one chromosome from each parent that harbour the transgene. 
 
Double transgenic, heterozygous offspring were raised until fertility and mated 
amongst or crossed to other single or double transgenic individuals. The first results in 
homozygous, hemizygous and wild-type F2 individuals, from which homozygous ones 
can be identified as described above. In the other case, triple or quadraple transgenic, 
hemizygous fish can be derived. From these, if crossed inter se multiple transgenic, 
homozygous lines can be established. During the project, homozygous and hemizygous 
Nestin-Neurogenin (Figure 2.), Nestin-GATA (Figure 3.), GATA-Fli (Figure 4.), Fli-
Neurogenin (Figure 5.), Fli-Nestin Neurogenin (Figure 6.), Fli-Nestin-GATA (Figure 7.), 
and Fli-Nestin-Neurogenin-GATA (Figure 8.) transgenic zebrafish were produced from 
the available lines (GATA-1, Fli, Nestin and Neurogenin) expressing green and red 
fluorescent proteins in the blood cells, blood vessels and nervous tissues. 
 
 
Figure 2. Fluorescent image of a 3 dpf (days post fertilization) Nestin-Neurogenin transgenic zebrafish fry (A: green 
/GFP/ filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
AA-- --BB 
A-B- 
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Figure 3. Fluorescent image of a 3 dpf (days post fertilization) Nestin-GATA transgenic zebrafish fry (A: green /GFP/ 
filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
Figure 4. Fluorescent image of a 3 dpf (days post fertilization) GATA-Fli transgenic zebrafish fry (A: green /GFP/ 
filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
Figure 5. Fluorescent image of a 3 dpf (days post fertilization) Fli-Neurogenin transgenic zebrafish fry (A: green /GFP/ 
filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
Figure 6. Fluorescent image of a 3 dpf (days post fertilization) Fli-Nestin-Neurogenin transgenic zebrafish fry (A: 
green /GFP/ filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
Figure 7. Fluorescent image of a 3 dpf (days post fertilization) Fli-Nestin-GATA transgenic zebrafish fry (A: green 
/GFP/ filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
 
Figure 8. Fluorescent image of a 3 dpf (days post fertilization) Fli-Nestin-Neurogenin-GATA transgenic zebrafish fry 
(A: green /GFP/ filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
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As liver is also one of the main target organs of toxicity, and at the beginning of 
the project, no lines expressing fluorescent protein in the liver existed, a new transgenic 
line needed to be generated. 
In order to establish the new line, first we needed to specify a gene of a protein 
produced only in the liver and a gene of a fluorescent protein (as a visible marker.) 
From liver specific genes, vitellogenins are among the most suitable genes for 
building the construct for transgenesis. Vitellogenins in the absence of inducers are 
normally synthetised only in females, so as vitellogenins are inducible by estrogenic 
substances, besides following liver development (and detecting abnormalities as effects 
of toxic agents) the male individuals from the liver transgenic line derived this way could 
also be used for screening Endocrine Disrupting Chemicals (EDC) e.g. in pesticides, 
herbicides, drugs, wastewaters. Zebrafish has 7 vitellogenin genes from which 
vitellogenin-1 (vtg-1) has the strongest expression. Therefore the promoter of 
vitellogenin-1 was chosen for establishing the new transgenic line. If the vitellogenin 
promoter is followed by the gene of a fluorescent protein in the construct, the promoter 
will guide the expression of this protein. For this purpose, a red (mCherry) and a blue 
fluorescent protein (EBFP) was chosen (as visible markers of vitellogenin synthesis in the 
liver). 
Instead of using BAC clones, the highly efficient transposon-based Gateway 
cloning system was used for the establishment of the transgenic line. BAC clones are 
large DNA sequences (100-300 kbp) difficult to work with and the efficiency of 
transgenesis is low (<5%). The Gateway vector is much smaller (3-8 kbp), easier to work 
with and provides much higher transgenesis efficiency (>80%). The Gateway system is 
fast and dynamic. 
The Gateway system is a two-step system in which cloning is based on site-
specific recombination making cloning much more efficient than the traditional 
endonuclease based method. First the genes of interest (in this case the vitellogenin 
promoter and the fluorescent protein gene) should be amplified by a special PCR using 
primers that have the attachment sites needed for the recombination on their ends. We 
looked up the genomic sequence of the vtg-1 gene in the databases (NCBI, Ensembl) and 
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analysed the region upstream the presumed transcription start site. A 4200 bp, then as the 
first construct did not work, a 3400 bp fragment (harbouring the transcription start site 
and the upstream regulatory sequences as well) was amplified from zebrafish genomic 
DNA. The fluorescent protein gene was amplified in the same way, using the encoding 
PCS2 plasmid (Figure 9.).  
 
 
 
 
Figure 9. Gel electrophoretic images of the amplified fluorescent protein (mCherry) gene (A) and the vitellogenin-1 
promoter (B) 
 
Fragments were cleaned up from the agarose gel and their sequence was 
analysed. PCR products were then cloned separately to circular plasmid DNA vectors 
called donor vectors, and finally to the Gateway itself (Figure 10.). 
 
A 
B 
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Figure 10. Establishment of the liver-specific construct by using the Gateway cloning system 
 
When the construct is ready (the Gateway is holding the promoter and the 
fluorescent protein as well) it was linearized by restriction digestion. As the gene and 
promoter of interest are built between Tol2 transposon arms, to achieve the best transgene 
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integration efficiency, the mRNA of the transposase enzyme is also needed. Transposase 
mRNA was synthetized from the encoding PCS2 plamid by using an in vitro transcription 
kit. 
The construct (along with the mRNA) was injected to 1-2 cell wild-type and 
transgenic zebrafish embryos (Figure 11., 12., 13.), resulting single, double or multiple 
transgenic individuals. 
 
 
Figure 11. Microinjection of the liver-specific construct to the yolk of 1-2 cell zebrafish embryos 
 
Embryos were raised on 27 oC, in 100 mm petri dishes containing zebrafish 
embryo medium. Transgene expression was induced by 100 ng/l estrogen (E2). As the 
liver in zebrafish only starts to develop on the 3rd-4th day post fertilization (3-4dpf), P0 
individuals were treated with estrogen only after reaching this age and examined under 
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the fluorescent microscope at 10 dpf (Figure 12., 13., 14.). Liver-specific fluorescent 
protein expression was detected in 12 % of the injected wild-type and 32 % of the 
transgenic embryos. Transient, non-specific expression was detected in the eye, kidney 
and in the yolk. Liver specific expression was only detectable in embryos treated with 
estrogen (E2), while the expression in the yolk was much lower in non-induced embryos. 
These results correspond to those of other transposon based constructs. 
 
 
Figure 12. Fluorescent image of 10 dpf, injected Fli-Neurogenin transgenic fry following estrogenic treatment (100 
ng/l E2). (A: green /GFP/ filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
Figure 13. Fluorescent image of 10 dpf, injected Nestin-Neurogenin transgenic fry following estrogenic treatment (100 
ng/l E2). (A: green /GFP/ filter, B: red /mCherry/ filter, C: green /GFP/ +  red /mCherry/ filter) 
 
 
Figure 14. Fluorescent image of 10 dpf, injected wild-type fry following estrogenic treatment (100 ng/l E2). 
 
The injected P0 individuals are mosaic for the transgene integration, so only the 
genome of certain cells carry the transgene. Therefore individuals that harbour the 
transgene in their gametes and so transmitting the construct needed to be identified. P0 
individuals were crossed to wild-type partners and following estrogenic treatment, 
fluorescent protein expression was observed under the fluorescent microscope. From the 
examined 38 wild-type males, 7, while from the injected 12 GATA-Fli males, 2 
transmitted the transgene. In case of females, offspring of 8 inherited the transgene from 
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the examined 50. According to these, 18% of the males and 16% of the females had 
“transgene carrying” gametes, and about 40% of their offspring produced fluorescent 
signal (mCherry) in the liver. Our results correspond to the expected and to the results of 
other similar experiments. 
Transgene transmission to subsequent generations was also confirmed at the 
molecular level. Therefore a PCR reaction, specific for the mCherry was developed, as 
the other main component of the construct, the vitellogenin promoter may not only be 
introduced by the construct but is naturally present in the genome. The PCR amplifies a 
158 bp fragment of the mCherry and is also suitable for the construct copy number 
determination. In the reactions we used mCherry as positive control and the genomic 
DNA of non-injected, wild-type zebrafish as negative control. DNA was prepared from 
embryos by the phenol-chloroform method, and PCR reactions were performed. Results 
confirmed that individuals selected on the basis of microscopic analysis could indeed 
transmit the transgene. 
In order to develop the F1 generation of liver transgenic lines, P0 individuals 
were crossed to wild-type or homozygous transgenic partners. As the transgene in 
different P0 individuals integrated to different chromosomal locations, they should be 
handled separately and should not be intercrossed. As in this generation, gonads are 
mosaic too, not all gametes and so not all offspring will carry the construct. As a cost 
effective, space saving solution, we raised the offspring for 1 month and selected the 
transgenic ones on the basis of PCR. Identification would also be possible by estrogenic 
induction, but the treatment is risky as not all individuals survive, delaying the generation 
of stable transgenic lines. As F1 individuals are presumably not mosaic, the presence of 
the transgene can be detected by the mCherry specific PCR (described above) from the 
tail fin DNA of hatchlings. The tail fin of one month old zebrafish is tiny, so a modified 
phenol-chloroform based DNA extraction method needed to be elaborated. PCR reactions 
were performed on the individually isolated DNA samples (Figure 15.). 
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Figure 15. PCR-based identification of 1 month old, transgenic F1 fry (from the left: 1.-2. molecular weight 
markers, 3. positive control, 4. negative control, 5.-18. PCR products of individual DNA samples). 
 
Hatchlings found to be positive on the basis of the mCherry specific PCR were 
raised up and up to now the F2 generation of 3 founders (P0) was established. F2 fry are 
being raised. 
Copy number and integration site of the transgene has not been yet determined. 
Offspring of founders and F1 are regularly bred (every week) and the resulting larvae are 
subjected to estrogenic treatment. As both the integration site and the copy number may 
affect the intensity of the induced fluorescent signal, we decided to identify those F1 and 
F2 individuals that show the highest inducibility prior to the determination of other 
characteristics at the molecular level. Based on these, further on lines carrying the 
transgene in more copies could also be generated. 
 
In the project one of our aims was to develop the liver-specific transgene 
construct with the gene of an other fluorescent protein, the EBFP (Enhanced Blue 
Fluorescent Protein) too. The excitation and emission spectrum of this protein does not 
overlap with the other fluorescent proteins present in the multiple transgenic line thus by 
injecting the construct, multiple transgenic lines expressing proteins of three different 
colours could be generated. We attempted to develop the construct twice, but the 
fluorescent protein expression in both cases was so weak, the signal was nearly invisible. 
So we started to build the construct by using a new blue fluorescent protein, the CFP 
(Cyan Fluorescent Protein). Although the spectrum of this overlap with that of the green 
fluorescent protein, the signal it produces will surely be much more intensive. 
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In summary, we developed a new transgene construct that drives inducible 
fluorescent protein expression in the liver. This construct was injected to 1-2 cell wild-
type and transgenic zebrafish embryos and the F1 and F2 generation of 3 founders was 
established. The determination of the transgene integration site and copy number is in 
progress, however, in order to save cost, it will be performed only on individuals showing 
the highest fluorescent signal inducibility as a response to estrogenic treatment. In the 
framework of this project, double transgenic, homozygous F2 individuals and 
hemizygous, multiple transgenic fish were produced from the available single transgenic 
lines in which the blood cells, the blood vessels or the nervous tissues are fluorescently 
labelled. We found out, that the EBFP is not a suitable reporter for developing such 
transgenic lines, as the signal it produces is too weak to be detectable. So a new blue 
fluorescent protein (CFP) was selected for building a new, blue construct. Purchasing the 
encoding plasmid also caused a delay. 
Further on, the newly developed transgenic lines would enable the in vivo 
identification of toxic effects exerted on the fluorescently labelled tissues and organs and 
to determine the estrogenic effect of new agents or complex environmental samples. The 
lines could also be useful when characterizing pharmaceuticals, during the risk 
assessment of pollutants released to the environment, natural waters and fish ponds or 
sludge, and treated wastewater and effluents. EDC levels exceeding a certain estrogen 
(E2) equivalent could also be evaluated with the help of the lines. Results on these 
transgenic fish could complete previous analytical tests, enabling more precise toxicity 
evaluation, and could also be a perfect tool in the risk assessment of environmental 
pollutants and for the determination of toxicity levels of agents. 
